Evolution of Fluconazole Resistance in Candida albicans [PDF]
, 2000 29 pages, 1 article*Evolution of Fluconazole Resistance in Candida albicans* (Nayadike, Nnaemeka; Greenblatt, Aaron; Ortega, Omayra; Engmen, Martin; Wirkus, Steven) 29 ...
Greenblatt, Aaron +7 more
core +6 more sources
The resistance to fluconazole in patients with esophageal candidiasis [PDF]
Arquivos de Gastroenterologia, 2009 CONTEXT: Esophageal candidiasis is often observed in patients with risk factors for its development and fluconazole is the therapeutic choice for the treatment of this disease. OBJECTIVES: To determine its frequency, by performing upper digestive endoscopy; to determine Candida species involved in its pathogenesis and verify their distribution ...
Wilheim, Ana Botler +5 more
openaire +4 more sources
Candida norvegensis: a fluconazole-resistant species [PDF]
Antimicrobial Agents and Chemotherapy, 1997 Candida norvegensis has been an unusual cause of infections in humans. In Norway this species was isolated from eight patients from 1990 to 1996 and was of probable pathogenic significance in four of them. All isolates were resistant to fluconazole. The same was true for two C. norvegensis isolates from before 1940, and it is therefore assumed that the
P, Sandven +4 more
openaire +2 more sources
Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole [PDF]
Frontiers in Cellular and Infection Microbiology, 2017 In this study, we found that ambroxol hydrochloride (128 μg/mL) exhibits synergistic antifungal effects in combination with fluconazole (2 μg/mL) against resistant planktonic Candida albicans (C. albicans) cells. This combination also exhibited synergistic effects against resistant C.
Li, Xiuyun +5 more
openaire +2 more sources
Successful Treatment of Fluconazole-Resistant Oropharyngeal Candidiasis by a Combination of Fluconazole and Terbinafine [PDF]
Clinical Diagnostic Laboratory Immunology, 1999 ABSTRACT Increasing incidence of resistance to conventional antifungal therapy has demanded that novel therapies be introduced. Recent in vitro studies have shown that combinations involving azoles and allylamines may be effective in inhibiting fluconazole-resistant fungi.
M A, Ghannoum, B, Elewski
openaire +2 more sources
Fluconazole-resistant Candida parapsilosis: A new emerging threat in the fungi arena
Frontiers in Fungal Biology, 2022 Candida parapsilosis is a leading cause of invasive candidiasis in southern Europe, Latin America and Asia. C. parapsilosis has been mostly considered susceptible to triazoles, but fluconazole resistance is on the rise in some countries.
Pilar Escribano +4 more
doaj +1 more source
Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole [PDF]
Journal of Antimicrobial Chemotherapy, 2007 The fungal pathogen Candida albicans forms biofilms on implanted medical devices, resulting in infections with high mortality. Fully developed biofilms, which are adherent communities of microorganisms, characteristically exhibit high resistance to antimicrobial drugs, making treatment of device-associated infection problematic.
Igor, Bruzual +3 more
openaire +2 more sources
CAQ Corner: Basic concepts of transplant immunology
, 2022 Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley +1 more source
CAQ Corner: Immune‐mediated complications
, 2022 Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley +1 more source
Hsp90 governs dispersion and drug resistance of fungal biofilms [PDF]
, 2011 Fungal biofilms are a major cause of human mortality and are recalcitrant to most treatments due to intrinsic drug resistance. These complex communities of multiple cell types form on indwelling medical devices and their eradication often requires ...
Ramage Gordon +25 more
core +2 more sources